Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026)
Regenxbio (RGNX) posted Return on Equity [ROE] of -203.24% for Q2 2026, down 131.21 percentage points from -72.04% a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Regenxbio's Return on Equity [ROE] came in at -107.05%, down 27.56 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -80.17 percentage points (FY2020 to FY2025).
- In prior years, Regenxbio's Return on Equity [ROE] was -79.49% in FY2024 (-15.84 pp), -63.65% in FY2023 (-19.87 pp), -43.78% in FY2022 (-66.17 pp) and 22.39% in FY2021 (+49.26 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2015.
- On a year-over-year basis, Return on Equity [ROE] increased in 1 of the last seven quarters, with an average year-over-year change of -31.26 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 56.19 percentage points; the weakest was Q2 2026, with a drop of 131.21 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Regenxbio | 402.44 Mn | -530.65 Mn | - | -203.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -203.24% |
| Dec 31, 2025 | -146.84% |
| Sep 30, 2025 | -94.93% |
| Jun 30, 2025 | -72.04% |
| Mar 31, 2025 | -59.14% |
| Dec 31, 2024 | -81.02% |
| Sep 30, 2024 | -73.59% |
| Jun 30, 2024 | -65.31% |
| Mar 31, 2024 | -74.13% |
| Dec 31, 2023 | -78.14% |
| Sep 30, 2023 | -67.76% |
| Jun 30, 2023 | -62.95% |
| Mar 31, 2023 | -55.08% |
| Dec 31, 2022 | -51.91% |
| Sep 30, 2022 | 12.33% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | 13.93% |
| Dec 31, 2021 | 20.86% |
| Sep 30, 2021 | -43.86% |
| Jun 30, 2021 | -27.36% |
API Access
Regenxbio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();